ATRT
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Rhabdoid Tumors Cellular Architecture by Single-cell Analyses (InnovRT-2) (NCT04987476) | Assistance Publique - Hôpitaux de Paris | 2022-03-31 |
| Tazemetostat Expanded Access Program for Adults With Solid Tumors (NCT03874455) | Epizyme, Inc. |
Track ATRT automatically
Every clearance here is in the API, with alerts when new ones post.